期刊文献+

乙型肝炎病毒表面抗原阴性271例隐匿性感染的研究

Analysis of occult hepatitis B virus infection in 271 cases with serum HBsAg negative
下载PDF
导出
摘要 目的了解在乙型肝炎表面抗原(HBsAg)阴性人群中隐匿性感染情况。方法采用实时荧光定量聚合酶链反应检测271例重庆黔江区HBsAg阴性住院患者血清中HBV-DNA含量。结果271例HBsAg阴性人群血清HBV-DNA阳性率为10.7%,HBV-DNA含量均低于103copy/mL。HBV-DNA检出率与性别、年龄无关。在HBV-DNA阳性人群中抗-HBc抗体出现率较高,抗-HBs阳性或乙型肝炎病毒标志物全阴性也可检出HBV-DNA。结论血清HBsAg阴性者存在一定比例的隐匿性感染,对不明原因的肝损害、输血、器官移植等应结合灵敏度高的HBV-DNA检测结果再作判断。 Objective To investigate the prevalence of occult hepatitis B virus infection in population with serum hepatitis B surface antigen negative. Methods Real time fluorescent quantitative polymerase chain reaction (RT- PCR) was applied to measuring the serum content of HBV-DNA in 271 inpatients with serum HBsAg negative. Resuits The positive rate of serum HBV-DNA was 10.7% in 271 inpatients with serum HBsAg negative. The content of HBV-DNA was below 103 copies/mL, and the detection rate of HBV-DNA wasnlt associated with age and gender. Anti-HBc antibody was more common in HBV-DNA positive subjects and HBV-DNA was still detected in the samples of anti-HBs antibody positive or negative for any serological indicator of HBV. Conclusion Occult hepatitis B virus infection occurs in some hepatitis B surface antigen negative individuals, and it is necessary to introduce highly sensitive HBV-DNA detection method in case of cryptogenic hepatic lesion, blood transfusion, and organ transplantation.
出处 《检验医学与临床》 CAS 2008年第11期641-642,共2页 Laboratory Medicine and Clinic
关键词 乙型肝炎病毒 隐匿性感染 聚合酶链反应 hepatitis B virus occult infection polymerase chain reaction
  • 相关文献

参考文献3

二级参考文献67

  • 1朱晓洁,庄辉,朱万孚,马为民,许诚,徐德忠,鲁晓岚,陈亚洁,魏保勋,娄国强,马廷贤.我国6城市急性散发性病毒性肝炎的病原学和流行病学研究[J].中国公共卫生,1996,12(2):58-60. 被引量:32
  • 2朱晓洁,庄辉,朱万孚,朱永红,徐国民.戊型肝炎病毒核酸逆转录-套式聚合酶链反应法的建立及应用[J].中华预防医学杂志,1996,30(6):334-336. 被引量:8
  • 3范金水 庄辉 朱哓洁 等.我国六城市血清学阳性和阴性乙型肝炎临床和流行病学特点比较研究[J].中华预防医学杂志,1996,30:17-19.
  • 4[1]Ganem D,Prince AM.Hepatitis B virus infection--natural history and clinical consequences.N Engl J Med 2004; 350:1118-1129
  • 5[2]Michalak TI.Immunology of hepatitis B virus.In:Colacino JM,Heinz BA.Hepatitis Prevention and Treatment.Basel,Switzerland:Birkh(a)user Verlang,2004:87-105
  • 6[3]Lok AS,McMahon BJ.Chronic hepatitis B.Hepatology 2001; 34:1225-1241
  • 7[4]Lavanchy D.Hepatitis B virus epidemiology,disease burden,treatment,and current and emerging prevention and control measures.J Viral Hepat 2004; 11:97-107
  • 8[5]Michalak TI.Occult persistence and lymphotropism of hepadnaviral infection:insights from the woodchuck viral hepatitis model.Immunol Rev 2000; 174:98-111
  • 9[6]Brechot C,Thiers V,Kremsdorf D,Nalpas B,Pol S,PaterliniBrechot P.Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen:clinically significant or purely "occult"? Hepatology 2001; 34:194-203
  • 10[7]Torbenson M,Thomas DL.Occult hepatitis B.Lancet Infect Dis 2002; 2:479-486

共引文献69

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部